Tratamiento sustitutivo con progenitores hemopoyéticos en las inmunodeficiencias primarias

Allergologia et Immunopathologia

Volumn 29, Issue 3, 2001, Pages 118-121

  Espanol Boren T ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Gene therapy; Hemopoietic progenitor cell transplantation; Primary immunodeficiencies; Severe Combined immunodeficiency; Wiskott Aldrich syndrome

Indexed keywords

ADENOSINE DEAMINASE; INTERLEUKIN 2 RECEPTOR;

BONE MARROW TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CYTOLOGY; DONOR; FETUS BLOOD; GENE THERAPY; GENETICS; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNE DEFICIENCY; INFANT; PRESCHOOL CHILD; REVIEW; SPAIN; STEM CELL MOBILIZATION; TREATMENT OUTCOME;

ADENOSINE DEAMINASE; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; FETAL BLOOD; GENE THERAPY; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; RECEPTORS, INTERLEUKIN-2; SEVERE COMBINED IMMUNODEFICIENCY; SPAIN; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0035349219     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0301-0546(01)79030-1     Document Type: Article

References (21)

1. Gatti RA, Meeuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphogenic immunological deficiency. Lancet 1968; 2: 1366-69.
2. Begovich AB, Erlich HA. HLA typing for Bone marrow transplantation. JAMA 1995; 273: 586-91.
3. Ortega JJ, Yaniv J, Rocha V et al. on behalf of Eurocord-CBTG. Cord blood transplant for inborn errors. Blood 1998; 92 (suppl 1): 291.
4. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignan disease. Lancet 1995; 346: 214-9.
5. Porta F, Friedrich W. Bone marrow transplantation in congenital immunodeficiency diseases. Bone Marrow Transplant 1998; 21 (suppl 2): 821-3.
6. Buckley RH, Schiff SE, Schiff IR et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508-16.
7. a. edición. Malden MA USA. Blackwell Science Inc, 1999: cap 99: 1154-72.
8. Ferrara JL. Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667-74.
9. Parkman R, Rappaport J, Geha et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone marrow transplantation. N Engl J Med 1978; 298: 921-7.
10. Reisner Y, Kapoor N, Kirpatrick D et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992; 80: 270-6.
11. Dalal I, Reid B, Doyle J et al. Matched unrelated bone marrow transplantation for combined Immunodeficiency. Bone marrow Trasplant 2000; 25: 613-21.
12. Thomas C, Le Deist F, Cavazzana-Calvo M et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 1995; 86: 1629-35.
13. Thomas C, deSaint Basile G, Le Deist F et al. Brief report: Correction of X-linked Hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 333: 426-9.
14. a ed., Philadelphia: Saunders 1998; 889-967.
15. Condotti F, Blaese RM. Gene therapy in Primary immunodeficiency diseases. A molecular and genetic approach. En: Ochs HD, Smith CIE, Puck JM eds. Oxford: Oxford Universites Press, 1999; 476-89.
16. DW. Clapp Somatic genetherapy into hematopoyetic cells. Clinics In Perinatology 1993; 20: 155-65.
17. Karlsson S. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 1991; 78: 2481-92.
18. Graham FL. Adenovirus vectors for high-efficiency gene transfer into mammalian cells. Immunol. Today 2000; 21: 426-7.
19. Blaese RM, Culver KW, Miller AD et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475-80.
20. Candotti F, Oakes S, Jonston JA et al. In vitro correcction of Jak-3 ceficient severe combined immunodeficiency by retroviral mediated genetransduction. J Exp Med 1996; 183: 2687-92.
21. Evans CH, Ghivizzani SC, Oligino TJ, Robbins PD. Gene therapy for autoinmune disorders. J Clin Immunol 2000; 20: 334-7.